169330 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
WEARING ARTICLE PROVIDED WITH TEST STRIP FOR DETECTING AMNIOTIC FLUID MARKER
#2METHOD FOR ANALYZING A TUMOR-SPECIFIC MARKER
#3SYSTEMS AND METHODS FOR GENERATING DROPLETS AND PERFORMING DIGITAL ANALYSES
#4Disposable Indicator
#5METHODS FOR TREATING ENDOMETRIAL AND OVARIAN HYPERPROLIFERATIVE DISORDERS
#6STRUCTURE-BASED PEPTIDES FOR DETECTION OF TRANSTHYRETIN AMYLOID FIBRILS AND AGGREGATES IN PREECLAMPSIA
#7FIBROBLAST GROWTH FACTOR BINDING PROTEIN 1 (FGFBP1) AS (BLOOD) BIOMARKER FOR THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME
#8IDENTIFICATION OF CERVICAL BIOMARKERS
#9DETECTION OF PREDICTORS OF PREECLAMPSIA
#10BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH
#11Birth Control Efficacy Monitoring Device
#12Device for Detecting Misfolded Proteins and Methods of Use Thereof
#13BIOSENSOR FOR MALE INFERTILITY
#14COMPOSITIONS FOR ENDOMETRIOSIS ASSESSMENT HAVING IMPROVED SPECIFICITY
#15KITS AND METHODS TO DISTINGUISH FALSE LABOR AND TRUE LABOR
#16ASSESSMENT OF PREECLAMPSIA USING ASSAYS FOR FREE AND DISSOCIATED PLACENTAL GROWTH FACTOR
#17SYSTEMS AND METHODS FOR GENERATING DROPLETS AND PERFORMING DIGITAL ANALYSES
#18SYSTEM FOR EVALUATING OVARIAN RESERVE FUNCTION OF SUBJECT
#19METHODS AND COMPOSITIONS FOR SIRT1 EXPRESSION AS A MARKER FOR ENDOMETRIOSIS AND SUBFERTILITY
#20MULTI-OMIC DETERMINATION OF FERTILITY FITNESS
#21PREECLAMPSIA DIAGNOSTIC DEVICES, SYSTEMS AND METHODS
#22SYSTEMS AND METHODS TO IDENTIFY AND TREAT SUBJECTS AT RISK FOR OBSTETRICAL COMPLICATIONS
#23MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA
#24BIOMARKER PANELS AND METHODS FOR PREDICTING PREECLAMPSIA
#25TOOLS FOR PREDICTING THE RISK OF PRETERM BIRTH
#26MEANS AND METHODS APPLYING sFlt-1/PIGF OR ENDOGLIN/PIGF RATIO TO RULE OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD
#27METHODS FOR PREDICTION AND MONITORING OF SPONTANEOUS PRETERM BIRTH
#28IDENTIFICATION OF UNIQUE BLOOD-BASED GENE EXPRESSION PROFILES IN CHILDREN WITH REGRESSIVE AUTISM SPECTRUM DISORDER (ASD) AND ILEOCOLITIS
#29TARGET-ASSOCIATED MOLECULES FOR CHARACTERIZATION ASSOCIATED WITH BIOLOGICAL TARGETS
#30BIOMARKERS FOR PREDICTING PRETERM BIRTH DUE TO PRETERM PREMATURE RUPTURE OF MEMBRANES (PPROM) VERSUS IDIOPATHIC SPONTANEOUS LABOR (PTL)
#31Systems and methods for generating droplets and performing digital analyses
#32NOVEL IMMUNODIAGNOSTIC DEVICE FOR DETERMINING NORMAL AND ABNORMAL PREGNANCY BY MEASURING DISTRIBUTION RATIO OF BETA CORE FRAGMENT HCG
#33JUP BIOMARKER FOR THE DIAGNOSIS OF DISEASES OR DISORDERS OF THE FEMALE REPRODUCTIVE TRACT
#34METHODS FOR DETECTING AND TREATING ENDOMETRIOSIS
#35BIOMARKERS FOR PROGNOSIS OF EARLY ONSET PREECLAMPSIA
#36SYSTEMS AND METHODS FOR THE ANALYSIS OF BIOLOGICAL SAMPLES
#37RATIOS OF sFlt-1 TO P1GF OR ENDOGLIN TO P1GF AS BIOMARKERS FOR PREECLAMPSIA RELATED ADVERSE OUTCOMES AFTER BIRTH
#38METHODS OF PREDICTING PRE TERM BIRTH FROM PREECLAMPSIA USING METABOLIC AND PROTEIN BIOMARKERS
#39ASSAY METHOD FOR RELAXIN
#40TESTING METHOD AND TESTING REAGENT
#41METHODS FOR EMBRYO SCREENING
#42Systems and methods for generating droplets and performing digital analyses
#43BIOMARKER PAIRS FOR PREDICTING PRETERM BIRTH
#44DETECTION OF MICROPARTICLE-ASSOCIATED PROTEINS ASSOCIATED WITH SPONTANEOUS PRETERM BIRTH
#45USE OF FIBRONECTIN IN PREDICTING PREECLAMPSIA
#46BIOMARKER PAIRS AND TRIPLETS FOR PREDICTING PRETERM BIRTH
#47NOVEL BIOLOGICAL MARKERS IN THE DIAGNOSIS OF ENDOMETRIOSIS
#48METHOD OF PROGNOSING PREECLAMPSIA
#49BIOSENSOR IMPLEMENTING FP-WA COUPLING MODE, PREPARATION METHOD THEREFOR, AND USE THEREOF
#50Kits and methods to distinguish false labor and true labor
#51METHODS OF DETECTING PAPP-A AND RELATED METHODS FOR GESTATIONAL AGE ASSESSMENT
#52METHOD FOR PREDICTING THE FERTILITY POTENTIAL OF A FEMALE SUBJECT
#53METABOLIC PROFILE SCREENING FOR GESTATIONAL DIABETES
#54DIAGNOSIS AND TREATMENT OF PRIMARY GRAFT DYSFUNCTION FOLLOWING LUNG TRANSPLANT
#55BIOMARKER FOR DETERMINING FERTILITY, AND DETERMINING METHOD USING SAME
#56DYNAMIC MONITORING OF E3G, LH, PdG, FSH LEVELS IN FEMALE SUBJECTS TO PREDICT HEALTH CONDITIONS
#57Kits and methods for prediction and treatment of preeclampsia
#58SYSTEM AND METHOD FOR COLLECTION AND DISSEMINATION OF BIOLOGIC SAMPLE TEST RESULTS DATA
#59METHODS AND MATERIALS FOR ASSESSING AND TREATING HYPERTENSIVE DISORDERS
#60A METHOD OF EVALUATING SPERM HEALTH AND IDENTIFYING SPERM TO BE USED IN ASSIS REPRODUCTIVE TECHNOLOGIES
#61METHODS OF ASSESSING RISK OF AND TREATING PREECLAMPSIA AND SUBTYPES THEREOF
#62Pregnancy clock proteins for predicting due date and time to birth
#63SYSTEM FOR EVALUATING URINE FOR THE PRESENCE OR ABSENCE OF PREGNANEDIOL GLUCURONIDE AND OTHER HORMONES AND ANALYTES
#64EGG, FERTILIZED EGG, OR EMBRYO QUALITY IMPROVING AGENT
#65COMBINATION OF BIOMARKERS OF PRETERM DELIVERY
#66SYSTEMS, COMPOSITIONS AND METHODS OF DETERMINING VIABILITY OF EMBRYOS USING THE SAME
#67Systems and methods to identify and treat subjects at risk for obstetrical complications
#68CIRCULATING TROPHOBLASTS AS A NEW BIOMARKER FOR RISK ASSESSMENT OF MORBIDLY ADHERENT PLACENTATION
#69IDENTIFYING STATUS OF MALE FERTILITY BY DETERMINING SPERM CAPACITATION
#70TRANSMEMBRANE pH-GRADIENT POLYMERSOMES
#71COMPOSITIONS AND METHODS OF PREDICTING TIME TO ONSET OF LABOR
#72Target-associated molecules for characterization associated with biological targets
#73METHODS AND COMPOSITIONS FOR SIRT1 EXPRESSION AS A MARKER FOR ENDOMETRIOSIS AND SUBFERTILITY
#74antiRPS4Y1 mAb
#75AMH AND/OR INHIBIN B AS A BIOMARKER FOR AN EFFECT OF A TREATMENT TO IMPROVE MALE FERTILITY
#76DEVICE FOR DETECTING MISFOLDED PROTEINS AND METHODS OF USE THEREOF
#77Method for Determining Risk of Pre-Term Birth
#78A METHOD OF ASSESSING A FEMALE'S RISK OF HAVING PCOS AS WELL AS PRODUCTS AND USES RELATING THERETO
#79Method of making a polymersome
#80ANALYTIC METHOD AND KIT FOR DIAGNOSING RECURRENT MISCARRIAGE
#81PROBIOTIC FOR THE TREATMENT OF INFERTILITY AND RECURRENT PREGNANCY LOSS
#82DEVICES, ASSAYS AND METHODS OF TESTING PREECLAMPSIA
#83A METHOD OF DIAGNOSING AND/OR PROGNOSING PREECLAMPSIA
#84Biomarker for preeclampsia
#85ISOLATION OF FETAL CELLS USING FACS
#86Methods and Systems for Measuring Progesterone Metabolites
#87BIOMARKERS FOR PLACENTA ACCRETA SPECTRUM (PAS) DISORDERS
#88Detection and Treatment of Pregnancy Complications Comprising Determining Sialyl Lewis Antigens and Administering hCG
#89COMPOSITIONS FOR ENDOMETRIOSIS ASSESSMENT HAVING IMPROVED SPECIFICITY
#90METHOD FOR DETERMINING MALE INFERTILITY ASSOCIATED WITH ABNORMAL EXPRESSION OF SEX-DETERMINING GENE ON X CHROMOSOME (SDX) OR SDX PROTEIN
#91Identification of Unique Blood-Based Gene Expression Profiles in Children with Regressive Autism Spectrum Disorder (ASD) and Ileocolitis
#92PREECLAMPSIA BIOMARKERS AND USE THEREOF
#93ASSESSMENT OF PREECLAMPSIA USING ASSAYS FOR FREE AND DISSOCIATED PLACENTAL GROWTH FACTOR
#94USE OF CCDC157 GENE AND MUTANT GENES THEREOF AS MOLECULAR MARKERS IN DIAGNOSIS OF MALE INFERTILITY DISEASES
#95BIOMARKER COMPOSITION FOR DIAGNOSING PRE-ECLAMPSIA AND USE THEREOF
#96METHODS AND SYSTEMS FOR TREATING OR PREVENTING PREGNANCY-RELATED HYPERTENSIVE DISORDERS
#97LATERAL FLOW IMMUNOASSAY DEVICES AND METHODS OF USING SAME
#98PIF BINDING AS A MARKER FOR IMMUNE DYSREGULATION
#99SELECTION AND BLOCKADE OF FERTILIZATION COMPETENT MALE AND FEMALE GAMETES
#100Systems and Methods for Fertility Prediction and Increasing Culling Accuracy and Breeding Decisions
#101METHOD FOR DIAGNOSING AND MONITORING INFLAMMATORY DISEASE PROGRESSION
#102BIOMARKERS
#103Patch-Sized Apparatus And Method For Use With An Apparel To Detect Seminal Fluid
#104Device and Method for Pre-Term Birth Risk Assessment
#105ANALYZING HORMONE PANELS FOR THE PREDICTION OF SPONTANEOUS PRETERM DELIVERY
#106FERTILITY PREDICTION IN ANIMALS
#107Systems and methods for generating droplets and performing digital analyses
#108METHODS FOR DETERMINING RISK OF DEVELOPING INSULIN RESISTANCE
#109PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#110METHODS OF PREDICTING ENDOMETRIAL RECEPTIVITY
#111METHODS FOR PREDICTING TIME-TO-DELIVERY IN PREGNANT WOMEN
#112Targeted apheresis to treat preeclampsia
#113USE OF CAP-SCORE™ IN IDENTIFICATION OF A REPRODUCTIVE APPROACH IN MEN SUFFERING FROM VARICOCELE
#114ENDOMETRIAL RECEPTIVITY DETERMINATION
#115METHODS FOR PREDICTING AND REDUCING THE RISK OF PRETERM BIRTH
#116LIPOSOMAL PREPARATIONS FOR NON-INVASIVE-PRENATAL OR CANCER SCREENING
#117BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#118Biomarker Pairs of Preterm Birth
#119S100A9 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS
#120TROPHOBLAST STEM CELL, METHODS OF PREPARATION AND USES THEREOF
#121CATSPER-ACTIVITY-TEST FOR DETERMINING MALE INFERTILITY
#122A NON-INVASIVE PAPER BASED DEVICE FOR PREGNANCY DETECTION IN CATTLE AND BUFFALOES
#123Method for detection and interpretation of results indicated on a photographed diagnostic test
#124S100A6 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS
#125DYNAMIC OF SFLT-1 OR ENDOGLiN/PIGF RATIO AS AN INDICATOR FOR IMMINENT PREECLAMPSIA AND/OR HELLP SYNDROME
#126Kits and methods for prediction and treatment of preeclampsia
#127ANALYSIS AND SORTING OF MOTILE CELLS
#128Kits and methods to distinguish false labor and true labor
#129UTERINE ENDOMETRIAL FLUID FOR PREDICTION OF SUCCESS IN FERTILITY TREATMENT
#130METHOD FOR DETECTING IMMINENT CHILDBIRTH
#131USE OF AMNIOTIC FLUID PEPTIDES FOR PREDICTING POSTNATAL RENAL FUNCTION IN CONGENITAL ANOMALIES OF THE KIDNEY AND THE URINARY TRACT
#132MicroRNAs as biomarkers for endometriosis
#133System for the ovarian reserve function assessment of subjects
#134Methods and compositions for detecting misfolded proteins
#135DETERMINING FETAL LUNG MATURITY USING A MATERNAL SAMPLE
#136Biosensor for male infertility
#137Diagnostic assay and treatment for preeclampsia
#138INHIBITORS AND ANTAGONISTS OF GPR84 FOR THE TREATMENT OF ENDOMETRIOSIS
#139Health monitoring cat litter
#140Assessment of preeclampsia using assays for free and dissociated placental growth factor
#141COMPOSITIONS AND METHODS FOR DETERMINING RECEPTIVITY OF AN ENDOMETRIUM FOR EMBRYONIC IMPLANTATION
#142PREECLAMPSIA DIAGNOSTIC DEVICES, SYSTEMS AND METHODS
#143Biosensor for Male Infertility
#144DEVICE FOR DETECTING MISFOLDED PROTEINS AND METHODS OF USE THEREOF
#145METHOD AND SYSTEM FOR ESTIMATING WHETHER A FEMALE IS PREGNANT BASED ON A BLOOD SAMPLE
#146Preeclampsia biomarkers and related systems and methods
#147DIAGNOSIS OF ENDOMETRIOSIS BY DECREASED PROTEIN LEVELS OF BETA2-MICROGLOBULIN PROTEIN (BETA2M) AND ONE OR MORE FURTHER BIOMARKERS
#148System for evaluating urine for the presence or absence of pregnanediol glucuronide and other hormones and analytes
#149ISOLATION OF CIRCULATING CELLS OF FETAL ORIGIN USING RECOMBINANT MALARIA PROTEIN VAR2CSA
#150USE OF CIRCULATING MICROPARTICLES TO STRATIFY RISK OF SPONTANEOUS PRETERM BIRTH
#151TANDEM-PAIRED COLUMN CHEMISTRY FOR HIGH-THROUGHPUT PROTEOMIC EXOSOME ANALYSIS
#152METHODS AND KITS FOR DETECTING MISFOLDED PROTEINS
#153Detection of microparticle-associated proteins associated with spontaneous preterm birth
#154TEST DEVICE FOR DETECTING AN ANALYTE IN A SALIVA SAMPLE AND METHOD OF USE
#155Methods for diagnosing fertility of ejaculates for artificial insemination
#156Mass spectrometry assay for congenital adrenal hyperplasia
#157Isolation of fetal cells using FACS
#158CIRCULATORY BIOMARKERS FOR PLACENTAL OR FETAL HEALTH
#159BIOMARKERS FOR PREDICTING PRETERM BIRTH DUE TO PRETERM PREMATURE RUPTURE OF MEMBRANES (PPROM) VERSUS IDIOPATHIC SPONTANEOUS LABOR (PTL)
#160Biomarker pairs for predicting preterm birth
#161MicroRNAs as biomarkers for endometriosis
#162Assessment of preeclampsia using assays for free and dissociated placental growth factor
#163BIOMARKERS AND METHODS FOR PREDICTING PREECLAMPSIA
#164METHOD FOR DIAGNOSING CANINE PREGNANCY AND DIAGNOSTIC REAGENT THEREFOR
#165SYNCYTIOTROPHOBLAST EXTRACELLULAR VESICLES AS BIOMARKER FOR GESTATIONAL DIABETES MELLITUS
#166MEDICAL APPARATUS FOR TESTING FOR MEDICAL CONDITIONS INCLUDING ZIKA AND PREGNANCY
#167Microfluidics system
#168BIOMARKERS AND USES THEREOF
#169PEPTIDES OF BROMODOMAIN TESTIS-SPECIFIC PROTEIN (BRDT)
#170Methods for detecting and treating endometriosis
#171Motile sperm domain containing protein 2 and cancer
#172Egg, fertilized egg, or embryo quality improving agent
#173Methods and compositions for treating pre-eclampsia
#174METHODS OF PREDICTING PRE TERM BIRTH FROM PREECLAMPSIA USING METABOLIC AND PROTEIN BIOMARKERS
#175MARKERS OF ENDOPLASMIC RETICULUM STRESS IN OVARIAN FOLLICULAR FLUID PREDICT IVF SUCCESS
#176Ratios of sFlt-1 to P1GF or endoglin to P1GF as biomarkers for preeclampsia related adverse outcomes after birth
#177PIF-TRANSFECTED CELLS AND METHODS OF USE
#178Mass spectrometry assay for congenital adrenal hyperplasia
#179Antibody specifically binding to bovine pregnancy-associated glycoprotein 1 and use thereof
#180Biomarkers of Preterm Birth
#181DIAGNOSTIC APPARATUS, DIAGNOSTIC DEVICE AND DIAGNOSIS METHOD
#182LATERAL FLOW IMMUNOASSAY DEVICES AND METHODS OF USING SAME
#183IMMUNE AND GROWTH-RELATED BIOMARKERS ASSOCIATED WITH PRETERM BIRTH ACROSS SUBTYPES AND PREECLAMPSIA DURING MID-PREGNANCY, AND USES THEREOF
#184Transmembrane pH-gradient polymersomes for the quantification of ammonia in body fluids
#185POSITIVE ALLOSTERIC MODULATORS OF GABA A RECEPTOR
#186METHODS AND DEVICES FOR DETECTING BIOMARKERS ASSOCIATED WITH PREECLAMPSIA
#187PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#188METHODS OF DIAGNOSIS AND TREATMENT OF PRE-ECLAMPSIA
#189Detection and treatment of pregnancy complications comprising determining sialyl Lewis antigens and administering hCG
#190System of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
#191Method of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
#192Device for detecting misfolded proteins and methods of use thereof
#193DETECTION OF PREDICTORS OF PREECLAMPSIA
#194METHODS AND DEVICES FOR SEQUENCING
#195SYSTEMS AND METHODS FOR SAMPLE PREPARATION
#196METHOD FOR IMPROVING THE QUALITY AND QUANTITY OF OFFSPRING IN MAMMALS
#197DEVICES FOR PREGNANCY DETECTION AND CORRESPONDING METHODS THEREOF
#198Methods for identification of pregnancy failure
#199Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery
#200NON-INVASIVE PREIMPLANTATION GENETIC SCREENING
#201Biomarker pairs for predicting preterm birth
#202Mass spectrometry assay for congenital adrenal hyperplasia
#203Methods for measuring gene expression levels to identify viable oocytes
#204GAMETE-SECRETED GROWTH FACTORS
#205Diagnostic assay and treatment for preeclampsia
#206Method for determining the risk of preterm birth
#207Dual Indicator Light Pregnancy Testing Device
#208Methods and compositions for SIRT1 expression as a marker for endometriosis and subfertility
#209METHODS FOR ASSESSING THE PROBABILITY OF ACHIEVING ONGOING PREGNANCY AND INFORMING TREATMENT THEREFROM
#210METHODS FOR IMPROVED REPRODUCTIVE MANAGEMENT OF RUMINANT UNGULATES
#211METHODS FOR STAINING CELLS FOR IDENTIFICATION AND SORTING
#212Compositions and methods for treating endometriosis
#213A NEW BIOMARKER FOR PREECLAMPSIA
#214BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#215S100A8/S100A9-induced immunotolerance in newborn subjects
#216METHODS FOR IMPROVING FERTILITY IN ARTIFICIAL INSEMINATION
#217BIOMARKERS FOR PREDICTING PRETERM BIRTH IN A PREGNANT FEMALE EXPOSED TO PROGESTOGENS
#218Methods and compositions for detecting misfolded proteins
#219METHODS AND COMPOSITIONS FOR PROVIDING PREECLAMPSIA ASSESSMENT
#220Systems and methods for enhanced SCODA
#221In vitro method for identifying a pregnancy related disease
#222MARKERS AND THEIR RATIO TO DETERMINE THE RISK FOR EARLY-ONSET PREECLAMPSIA
#223BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#224ANALYSIS AND SORTING OF MOTILE CELLS
#225Systems and methods to identify and treat subjects at risk for obstetrical complications
#226COMPUTER-IMPLEMENTED METHODS OF ESTIMATING A PROBABILITY OF ECTOPIC PREGNANCY IN A SUBJECT, COMPUTER-READABLE MEDIA, AND METHODS OF DIAGNOSING AND TREATING A SUBJECT PRESENTING WITH A PREGNANCY OF UNKNOWN LOCATION (PUL)
#227METHODS FOR ASSESSING RISK OF INCREASED TIME-TO-FIRST-CONCEPTION
#228MicroRNAs as biomarkers for endometriosis
#229Kisspeptin-54 detection by tandem mass spectrometry
#230Pregnancy clock proteins for predicting due date and time to birth
#231SECRETOME PROFILE-FACILITATED IN VITRO FERTILIZATION
#232DYNAMIC OF SFLT-1 OR ENDOGLiN/PIGF RATIO AS AN INDICATOR FOR IMMINENT PREECLAMPSIA AND/OR HELLP SYNDROME
#233BIOMARKERS AND METHODS FOR PREDICTING PREECLAMPSIA
#234Method for preparing anti-AMH antibodies and uses of same
#235Assay Method For Determining The Risk Of Pre-Eclampsia
#236Pregnancy test device and method
#237METHOD OF TREATMENT AND PROGNOSIS
#238BIOMARKERS AND METHODS FOR PREDICTING PREECLAMPSIA
#239Analysis of amino acids in body fluid by liquid chromotography-mass spectrometry
#240System and method for determining risk of diabetes based on biochemical marker analysis
#241Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery
#242METHODS AND COMPOSITIONS FOR PROGNOSING PRETERM BIRTH
#243Target-associated molecules for characterization associated with biological targets
#244METHOD OF ANALYSING A BLOOD SAMPLE OF A SUBJECT FOR THE PRESENCE OF A FOETAL DISEASE OR CONDITION MARKER
#245Identification of unique blood-based gene expression profiles in children with regressive autism spectrum disorder (ASD) and ileocolitis
#246KIT FOR PREDICTING IMPLANTATION SUCCESS IN ASSISTED FERTILIZATION
#247Method for producing animal model of preterm birth and animal model of preterm birth produced by the method
#248MEDICAL APPARATUS FOR TESTING FOR MEDICAL CONDITIONS INCLUDING ZIKA, PREGNANCY, AND THE TORCH COMPLEX
#249MEDICAL APPARATUS FOR TESTING FOR MEDICAL CONDITIONS INCLUDING PREGNANCY AND THE TORCH COMPLEX
#250Medical apparatus for testing for medical conditions including zika and pregnancy
#251PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#252Tools for Predicting the Risk of Preterm Birth
#253MULTIPLEX ASSAYS FOR EVALUATING PROSTATE CANCER STATUS
#254DETECTION OF PROPER INSEMINATION TIME BY MULTIPLE PREGNANCY MARKER PATTERN (MPMP) RECOGNITION
#255Detection of risk of pre-eclampsia
#256Methods of predicting preeclampsia using biomarkers
#257Treatment of spontaneous preterm birth
#258Method for detecting chemical substances in samples of material that can be taken from a subject, in particular for detecting embryotoxic factors
#259PREIMPLANTATION SCREENING
#260IGFBP-7 as a marker of preeclampsia
#261Kits and methods for prediction and treatment of preeclampsia
#262Detection and treatment of pregnancy complications comprising determining sialyl Lewis antigens and administering hCG
#263Portable diagnostic system for ovulation cycle monitoring
#264Kits and methods to distinguish false labor and true labor
#265Systems and methods to predict risk for preterm labor and/or preterm birth
#266Methods for identification of pregnancy failure
#267PLASMONIC NANOPARTICLES AND LSPR-BASED ASSAYS
#268Diagnosis and treatment of preeclampsia
#269Medical Use
#270In vitro method for identifying a pregnancy related disease
#271Electronic analyte assaying device
#272Microparticle fractionation
#273Method for detecting plasminogen activator inhibitor-1 in a sample
#274HIGH-THROUGHPUT EARLY DETECTION AND POINT-OF-CARE EARLY DETECTION OF PREGNANT WOMEN SUSCEPTIBLE TO DEVELOPING PREECLAMPSIA
#275THERAPEUTIC STRATEGIES FOR THE TREATMENT OF PREECLAMPSIA
#276Compositions and methods for diagnosing and treating endometriosis-related infertility
#277Compositions and methods for determining receptivity of an endometrium for embryonic implantation
#278Mass spectrometry assay for congenital adrenal hyperplasia
#279Early determination of pregnancy status in ruminants
#280Determining candidate for induction of labor
#281Screening asymptomatic pregnant woman for preterm birth
#282BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#283Method and system for estimating whether a female is pregnant based on a blood sample
#284Method and system for estimating a gender of a foetus of a pregnant female
#285Use of soluble CD146 as a biomarker to select in vitro-fertilized embryo for implantation in a mammal
#286SYSTEM AND METHOD FOR DETERMINING RISK OF DIABETES BASED ON BIOCHEMICAL MARKER ANALYSIS
#287Methods for predicting time-to-delivery in pregnant women
#288SECRETOME PROFILE-FACILITATED IN VITRO FERTILIZATION
#289Methods for screening for fetal trisomies
#290Kisspeptin-54 detection by tandem mass spectrometry
#291Liposomal preparations for non-invasive-prenatal or cancer screening
#292Antibody Therapy for Amyloid Beta Disease
#293BIOMARKERS FOR PREDICTING PRETERM BIRTH IN A PREGNANT FEMALE EXPOSED TO PROGESTOGENS
#294Method for detecting AFP
#295METHODS AND SYSTEMS FOR ASSESSING FERTILITY BASED ON SUBCLINICAL GENETIC FACTORS
#296System and method for immediate health assessment response system
#297System and method for collection and dissemination of biologic sample test results data
#298Biomarkers for assessment of preeclampsia
#299INHIBITION OF AXL/GAS6 SIGNALING IN THE TREATMENT OF LIVER FIBROSIS
#300Pregnancy test device and method